Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms
Cancers · 06.08.2026 · 18 (15) · 2529
DOI: 10.3390/cancers18152529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 06.08.2026. Verfasst von Caroline Norup Bistrup und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nordic Bioscience A/S, 2730 Herlev, Denmark. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and objectives: Myeloproliferative neoplasms (MPNs) are blood cancers characterized by elevated blood cell counts, bone marrow fibrosis (BMF), and chronic inflammation, which drives disease progression. BMF results from disrupted collagen turnover in the bone marrow extracellular matrix (ECM), making its reduction or stabilization a key therapeutic goal. Non-invasive biomarkers reflecting collagen turnover could potentially improve early detection of BMF and monitor disease activity.
Methods
We evaluated serum biomarkers of collagen turnover in 130 MPN patients (MPN subtypes: ET = 49, PV = 60, pre-PMF = 8, PMF = 13) included in the DALIAH trial (ClinicalTrials.gov identifier: #NCT01387763). Type I and type III collagen formation (PRO-C1 and PRO-C3) and MMP-degraded type I, III, and IV collagens (C1M, C3M, and C4M) were measured by ELISA in serum. Biomarker levels were compared to age- and sex-matched healthy individuals and were assessed according to disease subtypes, somatic driver mutations, JAK2V617F VAF, and fibrosis grade. Furthermore, we studied correlations between the biomarker levels and conventional hematological markers for disease activity, such as hemoglobin, white blood cell count (WBCs), platelet counts, and lactate dehydrogenase (LDH).
Results
Baseline PRO-C3 (p = 0.0005) and C1M (p = 0.0102) were elevated in MPN patients compared to healthy individuals, whereas C3M was decreased (p < 0.0001). Patients with primary myelofibrosis (PMF) had higher levels of PRO-C3 compared to patients with ET (p = 0.0041) and PV (p = 0.0172), correlated with higher JAK2V617F VAF (≥50%) (p = 0.0069) and advanced fibrosis grade (p = 0.0002). In addition, PRO-C3 was positively correlated to LDH, which is a biomarker of disease activity in MPNs (r = 0.5754, p < 0.0001).
Conclusions
Taken together, these findings emphasize the role of ECM remodeling in MPN pathophysiology and the potential of soluble ECM neoepitopes as biologically plausible disease markers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nordic Bioscience A/S, 2730 Herlev, Denmark.
- Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
- Department of Hematology, Zealand University Hospital, 4000 Roskilde, Denmark.
- Department of Rheumatology, Odense University Hospital, 5000 Odense, Denmark.
ORCID-Profile: Caroline Norup Bistrup, Peter Junker, Vibe Skov, Trine Alma Knudsen, Morten Karsdal, Hans Carl Hasselbalch
Zitieren
APA
Bistrup, C. N., Larsen, M. K., Junker, P., Skov, V., Kjær, L., Knudsen, T. A., Karsdal, M., Willumsen, N., & Hasselbalch, H. C. (2026). Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms. Cancers, 18(15), 2529. https://doi.org/10.3390/cancers18152529
Vancouver
Bistrup CN, Larsen MK, Junker P, Skov V, Kjær L, Knudsen TA, et al. Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms. Cancers. 2026;18(15):2529. doi:10.3390/cancers18152529
BibTeX
@article{Bistrup2026,
author = {Bistrup, Caroline Norup and Larsen, Morten Kranker and Junker, Peter and Skov, Vibe and Kjær, Lasse and Knudsen, Trine Alma and Karsdal, Morten and Willumsen, Nicholas and Hasselbalch, Hans Carl},
title = {Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms},
journal = {Cancers},
year = {2026},
volume = {18},
number = {15},
pages = {2529},
doi = {10.3390/cancers18152529}
}
EUVIMED